These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7833297)

  • 1. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
    Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
    Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic therapy for chronic infection of pseudomonas in the lung.
    Høiby N
    Annu Rev Med; 1993; 44():1-10. PubMed ID: 8476233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
    Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.
    Denton M; Wilcox MH
    J Antimicrob Chemother; 1997 Oct; 40(4):468-74. PubMed ID: 9372414
    [No Abstract]   [Full Text] [Related]  

  • 8. Should pulmonary exacerbations in cystic fibrosis be treated with antibiotics?
    Bosso JA
    Drug Intell Clin Pharm; 1984 Oct; 18(10):825-6. PubMed ID: 6489166
    [No Abstract]   [Full Text] [Related]  

  • 9. Exacerbations in cystic fibrosis: 3--Management.
    Smyth A; Elborn JS
    Thorax; 2008 Feb; 63(2):180-4. PubMed ID: 18234661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME; Wingfield HJ; Batten JC
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials.
    Máiz L; Girón RM; Olveira C; Quintana E; Lamas A; Pastor D; Cantón R; Mensa J
    Expert Opin Pharmacother; 2013 Jun; 14(9):1135-49. PubMed ID: 23586963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
    Bellon G; Gilly R
    Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis.
    Deretic V; Schurr MJ; Yu H
    Trends Microbiol; 1995 Sep; 3(9):351-6. PubMed ID: 8520888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM
    Chest; 1988 Aug; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics.
    Wittenberg DF
    S Afr Med J; 1987 Mar; 71(5):335-6. PubMed ID: 3563765
    [No Abstract]   [Full Text] [Related]  

  • 18. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
    Høiby N; Koch C
    Thorax; 1990 Nov; 45(11):881-4. PubMed ID: 2256020
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas in cystic fibrosis sylph or sycophant?
    Fick RB
    Clin Chest Med; 1981 Jan; 2(1):91-102. PubMed ID: 7030601
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.